Resultados de procura - Jorge Alsina‐Fernandez
- Mostrando 1 - 7 Resultados de 7
-
1
The novel <scp>GIP</scp>, <scp>GLP</scp>‐1 and glucagon receptor agonist retatrutide delays gastric emptying por Shweta Urva, Libbey S. O’Farrell, Yu Du, Mei Teng Loh, Andrea Hemmingway, Hongchang Qu, Jorge Alsina‐Fernandez, Axel Haupt, Zvonko Miličević, Tamer Coşkun
Publicado 2023Artigo -
2
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept por Tamer Coşkun, Kyle W. Sloop, Corina Loghin, Jorge Alsina‐Fernandez, Shweta Urva, Krister Bokvist, Xuewei Cui, Daniel A. Briere, Over Cabrera, William C. Roell, Uma Kuchibhotla, Julie S. Moyers, Charles T. Benson, Ruth E. Gimeno, David A. D’Alessio, Axel Haupt
Publicado 2018Artigo -
3
Secretin-Activated Brown Fat Mediates Prandial Thermogenesis to Induce Satiation por Yongguo Li, Katharina Schnabl, Sarah-Madeleine Gabler, Monja Willershäuser, Josefine Reber, Angelos Karlas, Sanna Laurila, Minna Lahesmaa, Mueez U-Din, Andrea Bast‐Habersbrunner, Kirsi A. Virtanen, Tobias Fromme, Florian Bolze, Libbey S. O’Farrell, Jorge Alsina‐Fernandez, Tamer Coşkun, Vasilis Ntziachristos, Pirjo Nuutila, Martin Klingenspor
Publicado 2018Artigo -
4
GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior por Ricardo J. Samms, Richard Cosgrove, Brandy M. Snider, Ellen C Furber, Brian A. Droz, Daniel A. Briere, James D. Dunbar, Mridula Dogra, Jorge Alsina‐Fernandez, Tito Borner, Bart C. De Jonghe, Matthew R. Hayes, Tamer Coşkun, Kyle W. Sloop, Paul J. Emmerson, Minrong Ai
Publicado 2022Artigo -
5
GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist–Induced Nausea and Emesis in Preclinical Models por Tito Borner, Caroline E. Geisler, Samantha M. Fortin, Richard Cosgrove, Jorge Alsina‐Fernandez, Mridula Dogra, Sarah A. Doebley, Marcos J. Sanchez-Navarro, Rosa M. Leon, Jane Gaisinsky, Arianna White, Ankur Bamezai, Misgana Y. Ghidewon, Harvey J. Grill, Richard C. Crist, Benjamin C. Reiner, Minrong Ai, Ricardo J. Samms, Bart C. De Jonghe, Matthew R. Hayes
Publicado 2021Artigo -
6
Structural determinants of dual incretin receptor agonism by tirzepatide por Bingfa Sun, Francis S. Willard, Dan Feng, Jorge Alsina‐Fernandez, Qi Chen, Michal Vieth, Joseph D. Ho, Aaron D. Showalter, Cynthia Stutsman, Liyun Ding, Todd M. Suter, James D. Dunbar, John W. Carpenter, Faiz Ahmad Mohammed, Eitaro Aihara, Robert A. Brown, Ana B. Bueno, Paul J. Emmerson, Julie S. Moyers, Tong Sun Kobilka, Matthew P. Coghlan, Brian K. Kobilka, Kyle W. Sloop
Publicado 2022Artigo -
7
GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice por Ricardo J. Samms, Michael E. Christe, Kyla Collins, Valentina Pirro, Brian A. Droz, Adrienne K. Holland, Jessica L. Friedrich, Samantha Wojnicki, Debra L. Konkol, Richard Cosgrove, Ellen Paula Santos da Conceição, Xiaoping Ruan, Libbey S. O’Farrell, Annie M. Long, Mridula Dogra, Jill A. Willency, Yanzhu Lin, Liyun Ding, Christine C. Cheng, Over Cabrera, Daniel A. Briere, Jorge Alsina‐Fernandez, Ruth E. Gimeno, Julie S. Moyers, Tamer Coşkun, Matthew P. Coghlan, Kyle W. Sloop, William C. Roell
Publicado 2021Artigo
Ferramentas de procura:
Materias Relacionadas
Endocrinology
Internal medicine
Medicine
Agonist
Diabetes mellitus
Receptor
Type 2 diabetes
Biology
Glucagon-like peptide 1 receptor
Pharmacology
Adipose tissue
Area postrema
Biochemistry
Chemistry
Glucagon-like peptide-1
Incretin
Insulin
Liraglutide
Agonism
Alternative medicine
Brainstem
Diet-induced obese
Dopamine receptor D1
Downregulation and upregulation
Dulaglutide
Endogenous agonist
Exenatide
G protein-coupled receptor
Gastric emptying
Gene